Jacobs Levy Equity Management’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$269K Buy
+6,813
New +$269K ﹤0.01% 947
2025
Q1
Sell
-281,813
Closed -$9.85M 1139
2024
Q4
$9.85M Sell
281,813
-368,966
-57% -$12.9M 0.03% 308
2024
Q3
$26.1M Buy
650,779
+77,909
+14% +$3.12M 0.1% 191
2024
Q2
$27.3M Buy
572,870
+1,107
+0.2% +$52.8K 0.11% 182
2024
Q1
$24.8M Buy
571,763
+62,230
+12% +$2.7M 0.11% 186
2023
Q4
$25.8M Buy
509,533
+136,416
+37% +$6.9M 0.13% 174
2023
Q3
$16.9M Sell
373,117
-176,441
-32% -$8M 0.1% 200
2023
Q2
$22.5M Buy
549,558
+12,870
+2% +$528K 0.13% 180
2023
Q1
$19.2M Sell
536,688
-153,033
-22% -$5.47M 0.12% 196
2022
Q4
$26.1M Buy
689,721
+177,746
+35% +$6.71M 0.18% 157
2022
Q3
$22.6M Sell
511,975
-104,791
-17% -$4.63M 0.18% 150
2022
Q2
$22.8M Sell
616,766
-1,001,501
-62% -$37.1M 0.18% 148
2022
Q1
$59.9M Buy
1,618,267
+210,879
+15% +$7.81M 0.4% 59
2021
Q4
$42.8M Buy
1,407,388
+216,152
+18% +$6.58M 0.29% 89
2021
Q3
$40M Buy
1,191,236
+106,814
+10% +$3.58M 0.27% 97
2021
Q2
$43.3M Buy
1,084,422
+921,476
+566% +$36.8M 0.29% 92
2021
Q1
$7.33M Sell
162,946
-41,235
-20% -$1.85M 0.06% 349
2020
Q4
$11.5M Buy
204,181
+54,709
+37% +$3.09M 0.1% 232
2020
Q3
$7.09M Sell
149,472
-8,027
-5% -$381K 0.07% 277
2020
Q2
$9.29M Buy
157,499
+51,922
+49% +$3.06M 0.1% 230
2020
Q1
$4.99M Buy
105,577
+20,853
+25% +$986K 0.06% 293
2019
Q4
$5.12M Sell
84,724
-72,116
-46% -$4.36M 0.05% 369
2019
Q3
$9.4M Buy
156,840
+44,770
+40% +$2.68M 0.12% 222
2019
Q2
$7.2M Buy
112,070
+59,380
+113% +$3.82M 0.1% 263
2019
Q1
$4.28M Buy
+52,690
New +$4.28M 0.06% 357
2016
Q3
Sell
-136,900
Closed -$3.19M 1068
2016
Q2
$3.19M Buy
+136,900
New +$3.19M 0.07% 338
2015
Q2
Sell
-5,740
Closed -$365K 826
2015
Q1
$365K Buy
5,740
+500
+10% +$31.8K 0.01% 621
2014
Q4
$324K Sell
5,240
-2,320
-31% -$143K 0.01% 666
2014
Q3
$294K Buy
+7,560
New +$294K ﹤0.01% 682